ArticleThe Laryngoscope2026
Does Involvement of Medicine in Care of Head and Neck Free Tissue Transfer Patients Improve Outcomes?
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Does Involvement of Medicine in Care of Head and Neck Free Tissue Transfer Patients Improve Outcomes?The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate whether routine involvement of the medical hospitalist service (MHS) in postoperative medical management of head and neck cancer (HNC) patients undergoing major ablative head and neck surgery with free tissue transfer (FTT) improves inpatient outcomes.
methodsThis is a retrospective cohort study. Patients undergoing FTT after head and neck oncologic surgery between 2014 and 2022 were identified. Starting September 2018, MHS were involved in the medical care of every FTT patient (post-intervention). Prior to that, MHS were consulted on an as-needed basis (pre-intervention). Outcomes studied included transfer to a higher level of care (LOC), length of hospital stay (LOHS), 30-day readmission, and 90-day mortality. Data were analyzed using linear regression and generalized linear models.
resultsA total of 362 patients were included in this study (mean age 62.3 ± 10.5 and 30.1% females), 32.9% of the cohort being in the pre-intervention group. When comparing the post-intervention to pre-intervention groups, the risk difference (RD) for: (1) transfer to higher LOC was -7.4% (95% CI = -13.7 to -1.02, p = 0.02); (2) 30-day readmission was -4.4% (95% CI = -14.0 to 5.3%, p = 0.36); and (3) 90-day mortality was 2.4% (95% CI = -4.1 to 8.8, p = 0.49). Post-intervention, the LOHS decreased by 1.2 days compared to pre-intervention (95% CI = -3.9 to 1.5, p = 0.39).
conclusionInvolvement of MHS in the care of patients undergoing FTT halved the relative risk of transfer to higher LOC. There was no significant effect on mortality, readmission, or hospital stay. Further studies are needed to confirm our findings. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.